[1] A. Kaushik, S. Gupta, M. Sood, S. Sharma, and S. Verma, "A Systematic Review of Multisystem Inflammatory Syndrome in Children Associated With SARS-CoV-2 Infection," (in eng), Pediatr Infect Dis J, vol. 39, no. 11, pp. e340-e346, 11 2020, doi: 10.1097/INF.0000000000002888.
[2] I. Valverde et al., "Acute Cardiovascular Manifestations in 286 Children With Multisystem Inflammatory Syndrome Associated With COVID-19 Infection in Europe," (in eng), Circulation, vol. 143, no. 1, pp. 21-32, 01 05 2021, doi: 10.1161/CIRCULATIONAHA.120.050065.
[3] S. Godfred-Cato et al., "COVID-19-Associated Multisystem Inflammatory Syndrome in Children - United States, March-July 2020," (in eng), MMWR Morb Mortal Wkly Rep, vol. 69, no. 32, pp. 1074-1080, 08 14 2020, doi: 10.15585/mmwr.mm6932e2.
[4] M. Nelson, "Delayed Coronary Dilation with Multisystem Inflammatory Syndrome in Children," CONGENITAL HEART DISEASE NEVER TOO YOUNG OR TOO OLD TO BE DIAGNOSED WITH CONGENITAL HEART DISEASE, vol. 6, no. 1, p. 4, 2022.
[5] C. A. Capone et al., "Six Month Follow-up of Patients With Multi-System Inflammatory Syndrome in Children," (in eng), Pediatrics, vol. 148, no. 4, 10 2021, doi: 10.1542/peds.2021-050973.
[6] O. I. Hejazi, Y. H. Loke, and A. S. Harahsheh, "Short-term Cardiovascular Complications of Multi-system Inflammatory Syndrome in Children (MIS-C) in Adolescents and Children," (in eng), Curr Pediatr Rep, vol. 9, no. 4, pp. 93-103, 2021, doi: 10.1007/s40124-021-00258-5.
[7] N. Abdel-Haq et al., "SARS-CoV-2-associated multisystem inflammatory syndrome in children: clinical manifestations and the role of infliximab treatment," (in eng), Eur J Pediatr, vol. 180, no. 5, pp. 1581-1591, May 2021, doi: 10.1007/s00431-021-03935-1.
[8] F. Sperotto, K. G. Friedman, M. B. F. Son, C. J. VanderPluym, J. W. Newburger, and A. Dionne, "Cardiac manifestations in SARS-CoV-2-associated multisystem inflammatory syndrome in children: a comprehensive review and proposed clinical approach," (in eng), Eur J Pediatr, vol. 180, no. 2, pp. 307-322, Feb 2021, doi: 10.1007/s00431-020-03766-6.
[9] L. R. Feldstein et al., "Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19," (in eng), JAMA, vol. 325, no. 11, pp. 1074-1087, 03 16 2021, doi: 10.1001/jama.2021.2091.
[10] L. R. Feldstein et al., "Multisystem Inflammatory Syndrome in U.S. Children and Adolescents," (in eng), N Engl J Med, vol. 383, no. 4, pp. 334-346, 07 23 2020, doi: 10.1056/NEJMoa2021680.